These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24639110)

  • 1. Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages.
    Gao L; Yu S; Zhang X
    Cell Biochem Biophys; 2014 Sep; 70(1):273-7. PubMed ID: 24639110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
    Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].
    Kikushige Y
    Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.
    Kikushige Y; Akashi K
    Ann N Y Acad Sci; 2012 Aug; 1266():118-23. PubMed ID: 22901263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.
    Kikushige Y; Shima T; Takayanagi S; Urata S; Miyamoto T; Iwasaki H; Takenaka K; Teshima T; Tanaka T; Inagaki Y; Akashi K
    Cell Stem Cell; 2010 Dec; 7(6):708-17. PubMed ID: 21112565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
    Kikushige Y; Miyamoto T
    Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells.
    Lee WS; Ye Z; Cheung AMS; Goh YPS; Oh HLJ; Rajarethinam R; Yeo SP; Soh MK; Chan EHL; Tan LK; Tan SY; Chuah C; Chng WJ; Connolly JE; Wang CI
    Mol Cancer Ther; 2021 Sep; 20(9):1702-1712. PubMed ID: 34158344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
    Jajosky AN; Coad JE; Vos JA; Martin KH; Senft JR; Wenger SL; Gibson LF
    Stem Cells Transl Med; 2014 Jul; 3(7):836-48. PubMed ID: 24855276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia.
    Wang Z; Chen J; Wang M; Zhang L; Yu L
    Front Immunol; 2021; 12():618710. PubMed ID: 33868234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectins as regulators of cell survival in the leukemia niche.
    Ruvolo PP
    Adv Biol Regul; 2019 Jan; 71():41-54. PubMed ID: 30245264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways.
    Kikushige Y
    Cancer Sci; 2021 Sep; 112(9):3419-3426. PubMed ID: 34159709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.
    Kikushige Y; Miyamoto T
    Int J Hematol; 2013 Dec; 98(6):627-33. PubMed ID: 24046178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells.
    Gonçalves Silva I; Gibbs BF; Bardelli M; Varani L; Sumbayev VV
    Oncotarget; 2015 Oct; 6(32):33823-33. PubMed ID: 26413815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell dissection reveals promotive role of ENO1 in leukemia stem cell self-renewal and chemoresistance in acute myeloid leukemia.
    Tian Y; Guo J; Mao L; Chen Z; Zhang X; Li Y; Zhang Y; Zha X; Luo OJ
    Stem Cell Res Ther; 2024 Oct; 15(1):347. PubMed ID: 39380054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
    Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia.
    Wu Z; Ou J; Liu N; Wang Z; Chen J; Cai Z; Liu X; Yu X; Dai M; Zhou H
    Cancer Med; 2023 Apr; 12(7):8956-8969. PubMed ID: 36545697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway.
    Chen L; Guo Z; Zhou Y; Ni J; Zhu J; Fan X; Chen X; Liu Y; Li Z; Zhou H
    Aging (Albany NY); 2021 Apr; 13(10):13644-13662. PubMed ID: 33893245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia].
    Sakoda T; Kikushige Y
    Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.